|
|
Volumn 3, Issue 1, 2002, Pages 1-3
|
|
Pharmacogenomics and pharmacogenetics of neurodegenerative diseases: Towards new targets
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1,2,3,4 TETRAHYDRO 1 METHYL 8 (2 MORPHOLINYLMETHOXY)QUINOLINE;
ACETYLCHOLINE;
APOLIPOPROTEIN E;
CHOLINESTERASE;
CHOLINESTERASE INHIBITOR;
TACRINE;
AGING;
ALLELE;
ALZHEIMER DISEASE;
CONTROLLED STUDY;
DEGENERATIVE DISEASE;
DISEASE COURSE;
DRUG RESPONSE;
EDITORIAL;
GENE LINKAGE DISEQUILIBRIUM;
GENE MAPPING;
GENE TARGETING;
GENETIC VARIABILITY;
HUMAN;
LIFE EXPECTANCY;
MEDICAL RESEARCH;
MORBIDITY;
MULTIFACTORIAL GENETIC DISORDER;
PHARMACOGENETICS;
PHARMACOGENOMICS;
RISK FACTOR;
SINGLE NUCLEOTIDE POLYMORPHISM;
SOCIOECONOMICS;
ALZHEIMER DISEASE;
APOLIPOPROTEINS E;
GENOMICS;
HUMAN GENOME PROJECT;
HUMANS;
NEURODEGENERATIVE DISEASES;
PHARMACOGENETICS;
POLYMORPHISM, GENETIC;
|
|
EID: 0036208694
PISSN: 14622416
EISSN: None
Source Type: Journal
DOI: 10.1517/14622416.3.1.1 Document Type: Editorial |
|
Times cited : (5)
|
|
References (11)
|
